Gifthealth Partners with United Digestive to boost patient access and procedure prep. Gifthealth has announced a strategic ...

Rogers, chief scientific officer at Coronado Research, she shares insights on the evolving landscape of pharmaceutical ...

Private equity investors GHO Capital Partners and Ampersand Capital Partners have announced a merger agreement for the ...

Abbisko’s small molecule drug pimicotinib has smashed the primary goal of a phase 3 trial for the treatment of tenosynovial ...

Private equity investors GHO Capital Partners and Ampersand Capital Partners have announced a merger agreement for the ...

At CPHI Milan 2024, Abzena showcased its latest innovations in cell line development and ADC manufacturing, featuring the advanced AbZelectPRO platform and ThioBridge linker technology.

The Taiwanese biotech has launched a phase 1/2 trial to test its small molecule cancer therapy in children and young adults ...

Wegovy manufacturer Ascendis Pharma has been tasked with supporting the development of a once-monthly GLP-1 drug.

A new case study released by AllazoHealth reveals that a leading rare disease pharmaceutical company achieved a 10.4% increase in therapy initiation, driven by AI-enabled patient outreach and ...

As clinical trials evolve, electronic Clinical Outcome Assessments (eCOA) remain central to data quality but often lag in adoption due to complex setup and deployment challenges. Tim Davis, vice ...

Scemblix is the first drug to show superiority over all standard of care therapies for a rare type of leukemia.

Innovative radiotherapy offers a precision treatment alternative.